IS4274A - Imidazopyridine compounds for use in the treatment of gastrointestinal disorders - Google Patents

Imidazopyridine compounds for use in the treatment of gastrointestinal disorders

Info

Publication number
IS4274A
IS4274A IS4274A IS4274A IS4274A IS 4274 A IS4274 A IS 4274A IS 4274 A IS4274 A IS 4274A IS 4274 A IS4274 A IS 4274A IS 4274 A IS4274 A IS 4274A
Authority
IS
Iceland
Prior art keywords
treatment
gastrointestinal disorders
imidazopyridine compounds
imidazopyridine
compounds
Prior art date
Application number
IS4274A
Other languages
Icelandic (is)
Inventor
Birgitta Briving Carin
Peter Nordberg Mats
Ingemar Starke Carl
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4274A publication Critical patent/IS4274A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS4274A 1994-04-11 1995-03-20 Imidazopyridine compounds for use in the treatment of gastrointestinal disorders IS4274A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9401197A SE9401197D0 (en) 1994-04-11 1994-04-11 Active compounds

Publications (1)

Publication Number Publication Date
IS4274A true IS4274A (en) 1995-10-12

Family

ID=20393591

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4274A IS4274A (en) 1994-04-11 1995-03-20 Imidazopyridine compounds for use in the treatment of gastrointestinal disorders

Country Status (6)

Country Link
AU (1) AU2270695A (en)
IL (1) IL113263A0 (en)
IS (1) IS4274A (en)
SE (1) SE9401197D0 (en)
WO (1) WO1995027714A1 (en)
ZA (1) ZA952860B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2289542A1 (en) * 1997-05-28 1998-12-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Fused dihydropyrans
EE04677B1 (en) 1998-09-23 2006-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrah drop ridoethers, their use and medicine
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
MXPA02009552A (en) * 2000-03-29 2004-05-14 Altana Pharma Ag Alkylated imidazopyridine derivatives.
EA006095B1 (en) * 2000-03-29 2005-08-25 Алтана Фарма Аг Pyrano[2,3-c]imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders
KR100860627B1 (en) * 2000-03-29 2008-09-29 니코메드 게엠베하 Prodrugs of Imidazopyridine Derivatives
MXPA02009549A (en) * 2000-03-29 2004-05-14 Altana Pharma Ag Tricyclic imidazopyridines.
PL360412A1 (en) 2000-10-25 2004-09-06 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (en) 2000-12-07 2007-09-25 Алтана Фарма Аг Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix
NZ531433A (en) * 2001-08-03 2005-09-30 Altana Pharma Ag Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
WO2003014120A1 (en) * 2001-08-03 2003-02-20 Altana Pharma Ag Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
MXPA04001277A (en) * 2001-08-10 2004-05-27 Altana Pharma Ag TRICYCLID IMIDAZOPIRIDINS.
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
WO2004012659A2 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
CN100393720C (en) 2003-04-04 2008-06-11 奥坦纳医药公司 Cyclic benzimidazole compound
EP1697358A1 (en) * 2003-12-19 2006-09-06 Altana Pharma AG Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
US20070191334A1 (en) * 2004-03-17 2007-08-16 Altana Pharma Ag Tricyclic imidazopyridines
WO2007141253A1 (en) * 2006-06-07 2007-12-13 Nycomed Gmbh Process for the production of intermediates for the preparation of tricyclic imidazopyridines
EP2086543A2 (en) 2006-10-27 2009-08-12 The Curators of the University of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
JP2011512416A (en) 2008-02-20 2011-04-21 ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ Composition comprising a combination of omeprazole and lansoprazole and a buffer and method of using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines

Also Published As

Publication number Publication date
SE9401197D0 (en) 1994-04-11
ZA952860B (en) 1996-01-12
AU2270695A (en) 1995-10-30
WO1995027714A1 (en) 1995-10-19
IL113263A0 (en) 1995-10-31

Similar Documents

Publication Publication Date Title
IS4274A (en) Imidazopyridine compounds for use in the treatment of gastrointestinal disorders
DK1047428T3 (en) Use of morpholinol in the treatment of sexual disorders
EE04280B1 (en) Imidazopyrimidines and Imidazopyridines for the Treatment of Neurological Disorders
IS5113A (en) Use of CB1 antagonists for the treatment of craving disorders
EE200100480A (en) Xenon for use in the treatment of nerve poisoning
EE04390B1 (en) Topical preparation for the treatment of dermatological conditions
IS5921A (en) Substitute Benzopyran analogues for use in the treatment of inflammation
PT977748E (en) SUBSTITUTED BENZOPIRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION
ITMI951746A0 (en) DEVICE FOR THE TREATMENT OF DISPERSIONS
DE69503634D1 (en) STRUCTURE FOR HOLDING THE ANKLE
NO991459L (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
GB9816234D0 (en) Compounds for use in the treatment of inflammation
ITMI981984A0 (en) DEVICE FOR THE HEAT TREATMENT OF PARTS
DE69515779D1 (en) Grinding device
BR9712030A (en) Use of benzopyranes for the treatment of neurological disorders
DK0904070T3 (en) Use of the buckminster fuller for the treatment of neurotoxic lesions
NO20012612D0 (en) Isonipecotamides for the treatment of integrin-mediated disorders
IT1299630B1 (en) CONNECTION DEVICE FOR THE CONNECTION OF TWO BODIES
NO993549D0 (en) Imino-aza-anthracycline derivatives for the treatment of amyloidosis
DK1011678T3 (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
TR199501530A1 (en) Kit for use in the therapeutic cycle in the treatment of osteoporosis.
NO20002567D0 (en) Method and composition to improve the adhesive device
KR980000798U (en) Simple to use moxa moxa
PT1011678E (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
FI972637A0 (en) Use of vitamin K in the treatment of hyperthyroidism